{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:22:33Z","timestamp":1793978553170,"version":"4.8.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,9]],"date-time":"2022-11-09T00:00:00Z","timestamp":1667952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.ophtha.2022.08.027","type":"journal-article","created":{"date-parts":[[2022,8,31]],"date-time":"2022-08-31T03:27:56Z","timestamp":1661916476000},"page":"179-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["Vaccine-Associated Uveitis after COVID-19 Vaccination"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2426-3900","authenticated-orcid":false,"given":"Rohan Bir","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uday Pratap Singh","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6476-0066","authenticated-orcid":false,"given":"Francesca","family":"Kahale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4985-9855","authenticated-orcid":false,"given":"Aniruddha","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7532-9191","authenticated-orcid":false,"given":"Edmund","family":"Tsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2022.08.027_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(21)00043-7","article-title":"An interactive website tracking COVID-19 vaccine development","volume":"9","author":"Shrotri","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.ophtha.2022.08.027_bib2","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1038\/s41562-021-01122-8","article-title":"A\u00a0global database of COVID-19 vaccinations","volume":"5","author":"Mathieu","year":"2021","journal-title":"Nat Hum Behav"},{"key":"10.1016\/j.ophtha.2022.08.027_bib3","series-title":"Comirnaty and Pfizer-BioNTech COVID-19 Vaccine","year":"2020"},{"key":"10.1016\/j.ophtha.2022.08.027_bib4","unstructured":"U.S. Food and Drug Administration. Fact sheet for healthcare providers administering vaccine (vaccination providers). US Food and Drug Administration. https:\/\/www.fda.gov\/media\/144413\/download. www.modernatx.com\/covid19vaccine-. Accessed June 14,\u00a02022."},{"key":"10.1016\/j.ophtha.2022.08.027_bib6","unstructured":"Centers for Disease Control. The Vaccine Adverse Event Reporting System (VAERS) Request. United States Department of Health and Human Services (DHHS), Public Health Service (PHS), Centers for Disease Control and Prevention\/ Food and Drug Administration (FDA), Vaccine Adverse Event Reporting System 2022. https:\/\/wonder.cdc.gov\/vaers.html. Accessed August 12, 2022"},{"key":"10.1016\/j.ophtha.2022.08.027_bib7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3109\/15569520903427717","article-title":"Hepatitis B vaccine and uveitis: an emerging hypothesis suggested by review of 32 case reports","volume":"29","author":"Fraunfelder","year":"2010","journal-title":"Cutan Ocul Toxicol"},{"key":"10.1016\/j.ophtha.2022.08.027_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2174\/15748863113086660062","article-title":"Human papilloma virus vaccine associated uveitis","volume":"9","author":"Holt","year":"2014","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.ophtha.2022.08.027_bib9","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1097\/OPX.0000000000000682","article-title":"Bilateral iritis after vaccine for bladder cancer","volume":"92","author":"Parafita-Fern\u00e1ndez","year":"2015","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2022.08.027_bib10","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/OPX.0000000000001523","article-title":"Case report: Posterior uveitis after divalent human papillomavirus vaccination in an Asian female","volume":"97","author":"Ye","year":"2020","journal-title":"Optom Vis Sci"},{"key":"10.1016\/j.ophtha.2022.08.027_bib11","first-page":"3838","article-title":"Two cases of exudative retina detachment and uveitis following H1N1 influenza vaccination","volume":"124","author":"Tao","year":"2011","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/j.ophtha.2022.08.027_bib12","doi-asserted-by":"crossref","first-page":"e1035","DOI":"10.1542\/peds.2012-2930","article-title":"Anterior uveitis and cataract after rubella vaccination: a case report of a 12-month-old girl","volume":"132","author":"Ferrini","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/j.ophtha.2022.08.027_bib13","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1097\/ICB.0b013e318193491b","article-title":"Bilateral panuveitis after influenza vaccination","volume":"3","author":"Wells","year":"2009","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ophtha.2022.08.027_bib14","first-page":"48","article-title":"Vaccine-associated uveitis","volume":"113","author":"Benage","year":"2016","journal-title":"Mo Med"},{"key":"10.1016\/j.ophtha.2022.08.027_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0161-5890(91)90074-T","article-title":"Immunological adjuvants: desirable properties and side-effects","volume":"28","author":"Allison","year":"1991","journal-title":"Mol Immunol"},{"key":"10.1016\/j.ophtha.2022.08.027_bib16","article-title":"Uveitis sarcoidosis presumably initiated after administration of shingrix vaccine","volume":"11","author":"Heydari-Kamjani","year":"2019","journal-title":"Cureus"},{"key":"10.1016\/j.ophtha.2022.08.027_bib17","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/j.ophtha.2009.05.021","article-title":"Uveitis in a patient treated with Bacille-Calmette-Gu\u00e9rin. Possible antigenic mimicry of mycobacterial and retinal antigens","volume":"116","author":"Garip","year":"2009","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.08.027_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/09273948.2019.1626188","article-title":"Vaccine-associated uveitis","volume":"27","author":"Cunningham","year":"2019","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.08.027_bib19","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/vaccines10020342","article-title":"Ocular complications following vaccination for COVID-19: a one-year retrospective","volume":"10","author":"Haseeb","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ophtha.2022.08.027_bib20","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1080\/14740338.2021.1955101","article-title":"Thromboembolic events in younger women exposed to Pfizer-BioNTech or Moderna COVID-19 vaccines","volume":"20","author":"Sessa","year":"2021","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ophtha.2022.08.027_bib21","article-title":"COVID-19 mRNA vaccines are generally safe in the short term: a vaccine vigilance real-world study says","volume":"12","author":"Chen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ophtha.2022.08.027_bib22","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1001\/jama.2021.16496","article-title":"Association of receipt of the Ad26.COV2.S COVID-19 vaccine with presumptive Guillain-Barr\u00e9 Syndrome, February-July 2021","volume":"326","author":"Woo","year":"2021","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.ophtha.2022.08.027_bib23","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.2021.24110","article-title":"Myocarditis cases reported after mRNA-based COVID-19 vaccination in the US from December 2020 to August 2021","volume":"327","author":"Oster","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2022.08.027_bib24","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/ana.26339","article-title":"Neurological events reported after COVID-19 vaccines: an analysis of VAERS","volume":"91","author":"Frontera","year":"2022","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ophtha.2022.08.027_bib25","doi-asserted-by":"crossref","first-page":"7458","DOI":"10.1016\/j.vaccine.2020.09.072","article-title":"The reporting sensitivity of the Vaccine Adverse Event Reporting System (VAERS) for anaphylaxis and for Guillain-Barr\u00e9 syndrome","volume":"38","author":"Miller","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.ophtha.2022.08.027_bib26","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2021.04.054","article-title":"Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"39","author":"Welsh","year":"2021","journal-title":"Vaccine"},{"key":"10.1016\/j.ophtha.2022.08.027_bib27","unstructured":"Centers for Disease Control and Prevention (CDC). The Vaccine Adverse Event Reporting System (VAERS) Data Request. https:\/\/wonder.cdc.gov\/controller\/datarequest\/D8. Accessed June 7,\u00a02022."},{"key":"10.1016\/j.ophtha.2022.08.027_bib28","unstructured":"Anon. Welcome to MedDRA | MedDRA. https:\/\/www.meddra.org\/. Accessed May 18,\u00a02022."},{"key":"10.1016\/j.ophtha.2022.08.027_bib29","unstructured":"Centers for Disease Control and Prevention (CDC). CDC WONDER FAQs. https:\/\/wonder.cdc.gov\/wonder\/help\/faq.html#8. Accessed May 18,\u00a02022."},{"key":"10.1016\/j.ophtha.2022.08.027_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1001\/jamaophthalmol.2013.4237","article-title":"Incidence and prevalence of uveitis: results from the Pacific Ocular Inflammation Study","volume":"131","author":"Acharya","year":"2013","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.08.027_bib31","unstructured":"Anon. COVID-19 Vaccinations in the United States, Jurisdiction | Data | Centers for Disease Control and Prevention. https:\/\/data.cdc.gov\/Vaccinations\/COVID-19-Vaccinations-in-the-United-States-Jurisdi\/unsk-b7fc\/data. Accessed June 24,\u00a02022."},{"key":"10.1016\/j.ophtha.2022.08.027_bib32","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/s41586-021-03324-6","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","volume":"592","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ophtha.2022.08.027_bib33","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2022.08.027_bib34","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1056\/NEJMoa2101544","article-title":"Safety and efficacy of single-dose Ad26.COV2.S vaccine against Covid-19","volume":"384","author":"Sadoff","year":"2021","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ophtha.2022.08.027_bib35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s13037-021-00291-9","article-title":"Review the safety of Covid-19 mRNA vaccines: a review","volume":"15","author":"Anand","year":"2021","journal-title":"Patient Saf Surg"},{"key":"10.1016\/j.ophtha.2022.08.027_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ajo.2022.02.011","article-title":"COVID-19 vaccination and the eye","volume":"240","author":"Wang","year":"2022","journal-title":"Am J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ophtha.2022.08.027_bib37","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.ophtha.2022.05.015","article-title":"Association between vaccination with the BNT162b2 mRNA COVID-19 vaccine and non-infectious uveitis: a population-based study","volume":"129","author":"Tomkins-Netzer","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2022.08.027_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/archopht.1975.01010020227012","article-title":"Corneal endothelium in viral induced anterior uveitis. Ultrastructural changes following canine adenovirus type 1 infection","volume":"93","author":"Aguirre","year":"1975","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.08.027_bib39","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jtos.2020.11.002","article-title":"Prevalence of SARS-CoV-2 in human post-mortem ocular tissues","volume":"19","author":"Sawant","year":"2021","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ophtha.2022.08.027_bib40","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ajo.2021.05.008","article-title":"Presence of SARS-CoV-2 viral RNA in aqueous humor of asymptomatic individuals","volume":"230","author":"Koo","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2022.08.027_bib41","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1097\/IAE.0000000000003277","article-title":"Uveitis after the BNT162b2 mRNA vaccination against SARS-CoV-2 infection: a possible association","volume":"41","author":"Rabinovitch","year":"2021","journal-title":"Retina"},{"key":"10.1016\/j.ophtha.2022.08.027_bib42","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3390\/vaccines10020342","article-title":"Ocular complications following vaccination for COVID-19: a one-year retrospective","volume":"10","author":"Haseeb","year":"2022","journal-title":"Vaccines"},{"key":"10.1016\/j.ophtha.2022.08.027_bib43","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1021\/acscentsci.1c00197","article-title":"Modifications in an emergency: the role of N1-methylpseudouridine in COVID-19 vaccines","volume":"7","author":"Nance","year":"2021","journal-title":"ACS Cent Sci"},{"key":"10.1016\/j.ophtha.2022.08.027_bib44","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"A\u00a0focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.08.027_bib45","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/09273948.2016.1196713","article-title":"Ocular immunology and inflammation. A focus on the epidemiology of uveitis A focus on the epidemiology of uveitis","volume":"26","author":"Tsirouki","year":"2018","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ophtha.2022.08.027_bib46","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.695904","article-title":"Epidemiology and risk factors in non-infectious uveitis: a systematic review","volume":"8","author":"Joltikov","year":"2021","journal-title":"Front Med"},{"key":"10.1016\/j.ophtha.2022.08.027_bib47","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/rheumatology\/kew486","article-title":"Exploring the variability in Beh\u00e7et\u2019s disease prevalence: a meta-analytical approach","volume":"57","author":"Maldini","year":"2018","journal-title":"Rheumatology (Oxford)"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022006728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642022006728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:12:47Z","timestamp":1758982367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642022006728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S0161642022006728"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.08.027","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vaccine-Associated Uveitis after COVID-19 Vaccination","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2022.08.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}